NEW YORK (GenomeWeb) – HTG Molecular Diagnostics today set a price range of between $13 and $15 per share on its planned initial public offering, which could bring in up to $51.4 million in net proceeds, according to a document filed with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.